Jaguar Health (JAGX) EBT Margin (2015 - 2026)

Jaguar Health (JAGX) reported EBT Margin of 43.03% for Q1 2026, up 52162.0% year-over-year from N/an in Q1 2025, and up 106.0% quarter-over-quarter from 716.94% in Q4 2025.

Jaguar Health (JAGX) EBT Margin (2015 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 12 years of EBT Margin data on file, last reported at 43.03% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 43.03%, up 52162.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 117.28% (up 23313.0% YoY), and the FY2025 annual result was 469.09%, down 13330.0% from the prior year.
  • EBT Margin climbed to 43.03% in Q1 2026 per JAGX's latest filing, from 716.94% in the prior quarter.
  • Over five years, EBT Margin peaked at 43.03% in Q1 2026 and troughed at 90820.0% in Q1 2022.
  • A 5-year average of 8773.35% and a median of 398.47% in 2024 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 8985231 bps in 2022, then surged 6327111 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 25725.0% in 2022, then soared by 98 bps to 404.74% in 2023, then rose by 28 bps to 291.65% in 2024, then sank by 146 bps to 716.94% in 2025, then surged by 106 bps to 43.03% in 2026.
  • Business Quant data shows JAGX's EBT Margin at 43.03% in Q1 2026, 716.94% in Q4 2025, and 312.94% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 41.95%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Jaguar Health 1.44 Mn -10.19 Mn 19.11 Mn 43.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 43.03%
Dec 31, 2025 -716.94%
Sep 30, 2025 -312.94%
Jun 30, 2025 -354.48%
Mar 31, 2025 -478.59%
Dec 31, 2024 -291.65%
Sep 30, 2024 -322.43%
Jun 30, 2024 -353.84%
Mar 31, 2024 -398.47%
Dec 31, 2023 -404.74%
Sep 30, 2023 -280.98%
Jun 30, 2023 -459.30%
Mar 31, 2023 -27,548.89%
Dec 31, 2022 -25,725.00%
Sep 30, 2022 -400.29%
Jun 30, 2022 -321.47%
Mar 31, 2022 -90,820.00%
Dec 31, 2021 -670.63%
Sep 30, 2021 -1,935.24%
Jun 30, 2021 -3,715.30%